Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001144204-13-021025

Options or other derivatives

  • Chief Scientific Officer acquired 592,219 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

JOHE KARL · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-03-28 Grant or award : show line 1 in the form Common Stock Purchase Option +592,219 $1.12 2023-03-28 592,219 592,219 D
Loading xslF345X03/v340927_4.xml…